Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, is ...

A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product. Aptamer Group announced on Nov. 7, 2024 that one of its customers has advanced use ...

York-based biotech firm Aptamer Group has secured new contracts worth almost £500,000 with leading pharmaceutical companies.

Yorkshire life sciences company Aptamer has narrowed its losses after saying it made commercial and technical strides in ...

2024年10月14日，上海交通大学医学院附属仁济医院谭蔚泓院士团队在期刊《Signal Transduction and Targeted Therap》上发表了题为“Aptamer-drug conjugates-loaded ...

Aptamer Group, a developer of novel Optimer® binders to enable innovation in the life sciences industry, says it has extended ...

York biotech firm, Aptamer Group, has secured new contracts worth up to £471,000. In a commercial trading update the company reports it is "continuing the positive commercial traction" of the past ...

Life sciences business, Aptamer Group, has secured new contracts worth up to £471,000. Delivering an update an update on ...

Consequently, Aptamer Group is well-positioned moving into the new financial year, with ongoing work progressing through the lab and a robust sales pipeline. Strong technical delivery across ...

Level Zero Health's co-founders Ula Rustamova and Irene Jia are swinging for the fences. They are attempting to invent a ...